Material Event (Form 8-K)

Item 8.01 Other Events.

On March 20, 2026, Tevogen Bio Holdings Inc. (the "Company") received written notice (the "Notification Letter") from The Nasdaq Stock Market LLC notifying the Company that it had regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5450(a)(1) for continued listing on The Nasdaq Global Market. Accordingly, the matter is now closed. The Notification Letter was sent following the implementation of a 1-for-50 reverse stock split of the Company's common stock (the "Reverse Split"), which became effective on March 6, 2026. Additional information regarding the Reverse Split can be found in the Company's Current Report on Form 8-K filed on March 4, 2026.